在干眼病中基于德索尼德和桑坦的新型眼滴配方:非临床研究
Santa Viola1, Luca Rosario La Rosa1, Giuseppe De Pasquale1
1Innovation and Medical Science, SIFI S.p.A., 95025 Aci Sant'Antonio, Italy.
Pharmaceutics
|February 26, 2025
概括
一种新的眼药滴,XanterDES,有效地治疗干眼和炎症,用低剂量的皮质类固醇 (酸和酸) 和香甘,在动物研究中表现优于其他配方.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 生物材料科学 生物材料科学
背景情况:
- 眼睛表面的不适和刺激需要新的眼科配方.
- 为了解决眼睛表面问题,开发了一种新配方XanterDES,该配方含有香甘和酸 (DES) 的化 (desonide sodium phosphate).
- 与氨酸 (HYD) 配方进行了比较.
研究的目的:
- 评估XanterDES的药动力学特性.
- 描述XanterDES的风湿性和粘粘性行为.
- 在动物模型中比较XanterDES的疗效与HYD配方.
主要方法:
- 在LPS诱导的卵膜炎的子模型中测试了DES度.
- 在小鼠干眼模型中评估了XanterDES和HYD的疗效.
- 评估了使用类风湿学和纹理分析的类风湿学和粘粘性质.
主要成果:
- 低剂量DES (0.025%) 显著减少了皮膜炎中的角膜.
- 与HYD相比,XanterDES在干眼模型中的眼减少和角膜损伤的预防方面表现出更高的有效性.
- 克桑特德斯表现出伪塑性和增强的粘膜粘合性.
结论:
- 低剂量DES与香甘相结合,为眼睛表面平衡提供了有利的治疗特征.
- 与其他低剂量皮质类固醇配方相比,XanterDES表现出优越的药理动力学和生物物理性能.
- 该配方最大限度地降低了与标准皮质类固醇剂量相关的风险.
更多相关视频
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
2.3K
08:04A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
Published on: January 24, 2020
12.3K
相关概念视频
01:27Open Angle Glaucoma: Treatment
384
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
384
01:22Drug Delivery: Miscellaneous Routes
299
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
299